PAX7 Transcription Factor
"PAX7 Transcription Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A paired box transcription factor that is involved in EMBRYONIC DEVELOPMENT of the CENTRAL NERVOUS SYSTEM and SKELETAL MUSCLE.
| Descriptor ID |
D051763
|
| MeSH Number(s) |
D12.776.260.400.812 D12.776.260.645.875 D12.776.930.700.875
|
| Concept/Terms |
PAX7 Transcription Factor- PAX7 Transcription Factor
- Transcription Factor, PAX7
- Transcription Factor PAX7
- Factor PAX7, Transcription
- PAX7, Transcription Factor
- Paired Box Transcription Factor 7
- Paired Box Protein Pax-7
- Paired Box Protein Pax 7
|
Below are MeSH descriptors whose meaning is more general than "PAX7 Transcription Factor".
Below are MeSH descriptors whose meaning is more specific than "PAX7 Transcription Factor".
This graph shows the total number of publications written about "PAX7 Transcription Factor" by people in this website by year, and whether "PAX7 Transcription Factor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "PAX7 Transcription Factor" by people in Profiles.
-
Feng X, Juan AH, Wang HA, Ko KD, Zare H, Sartorelli V. Polycomb Ezh2 controls the fate of GABAergic neurons in the embryonic cerebellum. Development. 2016 06 01; 143(11):1971-80.
-
He WA, Berardi E, Cardillo VM, Acharyya S, Aulino P, Thomas-Ahner J, Wang J, Bloomston M, Muscarella P, Nau P, Shah N, Butchbach ME, Ladner K, Adamo S, Rudnicki MA, Keller C, Coletti D, Montanaro F, Guttridge DC. NF-?B-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest. 2013 Nov; 123(11):4821-35.
-
Taniguchi E, Cho MJ, Arenkiel BR, Hansen MS, Rivera OJ, McCleish AT, Qualman SJ, Guttridge DC, Scott MP, Capecchi MR, Keller C. Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma. Pediatr Blood Cancer. 2009 Aug; 53(2):136-44.